
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kenyan Red Pear contains phenolic compounds including quercetin derivatives and arbutin that inhibit acetylcholinesterase and butyrylcholinesterase enzymes for neuroprotective effects. Current research on similar pear cultivars demonstrates significant COX-1 and COX-2 inhibition (50-58%) along with potent antioxidant activity via FRAP mechanisms.

Reported Benefits (Provisional)
Origin & History

The Kenyan Red Pear (Pyrus communis 'Red Anjou' or similar high-altitude cultivar) is a distinctive fruit cultivated in the high-altitude regions of Kenya and East Africa. This pear variety is celebrated for its rich anthocyanin content and robust nutritional profile, making it a valuable functional food for cardiovascular, digestive, and cognitive health.
Research Narrative (Provisional)
Research on pear varieties, including those rich in anthocyanins, indicates significant antioxidant, anti-inflammatory, and cardiovascular benefits. Studies, including in vitro and animal models, highlight their potential for improving gut health and metabolic balance. Further human clinical trials specifically on Kenyan Red Pear cultivars would provide more targeted evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber (Pectin) - Vitamin C - Beta-carotene - Potassium - Magnesium - Iron - Anthocyanins - Flavonoids (Quercetin, Kaempferol) - Polyphenols
Reported Mechanism (Provisional)
Phenolic compounds including quercetin derivatives and arbutin inhibit acetylcholinesterase (15.1-23.4%) and butyrylcholinesterase (9.6-24.7%) at 100 mg/mL concentrations. Anti-inflammatory mechanisms involve COX-1 inhibition (mean 50.53%) and COX-2 inhibition (58.15%), while triterpenes like ursolic acid contribute to matrix metalloproteinase-9 reduction exceeding 50%. Antioxidant activity occurs through FRAP pathways with quercetin showing strong correlation (R²=0.83) to free radical scavenging capacity.
Clinical Narrative (Provisional)
Evidence for Kenyan Red Pear specifically remains limited, with no dedicated clinical trials identified in current literature. Research on related pear cultivars ('Radana', 'Conference') shows in vitro antiproliferative activity against bladder cancer cell lines and enzyme inhibition studies at laboratory concentrations. Human clinical trials are necessary to establish therapeutic efficacy, safety profiles, and optimal dosing parameters for this specific cultivar. Current evidence strength is preliminary and requires substantial clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







